Table 3.
Risk of Bias Assessment of Included Studies
Title and Year | Quality of Allocation Concealment | Analysis on Intention to Treat | No. and Description of Dropouts | Blinding—Participants | Blinding—Health Care Providers | Blinding—Outcome Assessors | Comparable Treatment and Placebo Groups |
---|---|---|---|---|---|---|---|
Alborzi 200811 | + | + | + | + | + | + | − |
Sugden 200812 | + | − | + | + | + | + | + |
Witham 201013 | + | U | + | + | + | + | + |
Harris 201114 | + | U | + | + | + | + | + |
Gepner 201215 | + | + | + | + | + | + | + |
Larsen 201216 | + | − | + | + | + | + | + |
Marckmann 201217 | + | − | + | + | + | + | + |
Sokol 201218 | + | + | U | + | + | + | + |
Stricker 201219 | + | + | + | + | + | + | − |
Witham 201220 | + | U | + | + | + | + | + |
Breslavsky 201321 | + | − | + | U | U | U | + |
Hewitt 201322 | + | U | + | + | + | + | + |
Witham 201323 | + | − | + | + | + | + | + |
Witham 201324 | + | + | + | + | + | + | + |
Witham 201325 | + | + | + | + | + | + | + |
Yiu 201326 | + | + | + | + | + | + | + |
Dreyer 201427 | + | + | + | + | + | + | + |
Martins 201428 | U | + | + | + | + | + | + |
Mose 201429 | + | U | + | + | + | + | + |
Ryu 201430 | U | − | + | + | + | + | + |
Zoccali 201431 | + | + | + | + | + | + | + |
Garg 201532 | U | − | + | + | + | + | + |
Pilz 201533 | + | + | + | + | + | + | + |
Thethi 201534 | U | U | U | + | + | U | + |
Witham 201535 | + | + | + | + | + | + | + |
Barchetta 201636 | + | − | + | + | + | + | + |
Borgi 201737 | + | + | − | + | + | + | + |
Bressendorff 201638 | + | U | + | + | + | + | + |
Dalan 201639 | + | + | U | + | + | + | − |
Forouhi 201640 | + | + | + | + | + | + | + |
Hin 201741 | + | + | + | + | + | + | + |
− indicates high risk of bias; +, low risk of bias; U, unclear risk of bias.